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A RANDOMISED CONTROLLED TRIAL TO COMPARE IMMUNOGENICITY 
BETWEEN INTRAMUSCULAR AND INTRADERMAL TRIVALENT 
INFLUENZA VACCINATION IN NURSING HOME OLDER ADULTS 
TC Chan, IFN Hung, KH Chan, PY Li, PTW Li, JKH Luk, LW Chu, FHW Chan 
 
Department of Medicine, Queen Mary Hospital and Fung Yiu King Hospital, Hong Kong 
 
BACKGROUND: Immunosenescence in older adults contributes to unsatisfactory 
immunogenicity towards influenza vaccine. Intradermal (ID) administration of influenza 
vaccine has been suggested to improve immunogenicity but there is no study regarding 
the immunogenicity of ID influenza vaccination in nursing home older adults. 
 
METHODS: This was a single-centre, randomised, controlled, open-label, parallel group 
trial from October 2013 to April 2014 in nine nursing homes comparing the 
immunogenicity and safety between full-dose intramuscular (IM) and ID immunisation of 
the trivalent influenza vaccine. Day-21 and day-180 immunogenicity of ID compared to 
IM vaccination was analysed. 
 
RESULTS: Overall, 100 nursing home older adults (mean age, 82.9 ± 7.4 years; male, 
36%) were randomised. Baseline characteristics were similar between the two groups. At 
day 21, non-inferiority in immunogenicity of the ID vaccination was demonstrated. The 
seroconversion rate of the H1N1 strain was significantly higher in the ID group. At day 
180, immunogenicity of both groups fell but the geometric mean titre (GMT) of all 
strains in the ID group was higher and the difference was significant for H3N2 strain. The 
seroconversion rate and GMT fold increase of H3N2 strain was significantly higher in the 
ID group. 
 
CONCLUSION: ID vaccination of influenza vaccine is non-inferior to IM vaccination in 
immunogenicity in nursing home older adults. Furthermore, ID vaccination is superior in 
some components of the immunogenicity assessment. 
